What is the maximum duration a Nasogastric (NG) tube can remain in place?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

An NG tube should not remain in place for more than 3-4 weeks due to the risk of sinusitis and other complications, as recommended by the most recent and highest quality study 1. The duration an NG (nasogastric) tube can remain in place typically ranges from 3-4 weeks, though this varies based on the type of tube and clinical situation.

Key Considerations

  • Short-term NG tubes made of polyvinyl chloride (PVC) should generally be replaced every 3-7 days, while softer silicone or polyurethane tubes can remain in place for up to 4-6 weeks, as suggested by earlier studies 1.
  • For patients requiring longer-term enteral feeding, a more permanent solution like a PEG (percutaneous endoscopic gastrostomy) tube should be considered after 3-4 weeks, as per the latest guidelines 1.
  • Regular assessment of the tube's condition is essential, including checking for signs of deterioration, blockage, or complications such as nasal tissue erosion, sinusitis, or aspiration.
  • The tube should be replaced immediately if it becomes clogged, damaged, or if the patient develops complications.

Clinical Implications

  • Healthcare providers should follow institutional protocols and regularly evaluate the continued need for the tube, removing it as soon as it's no longer clinically necessary.
  • A multidisciplinary team approach after enteral access placement provides improved patient care, with dietitians, nurses, and advanced practice clinicians assisting with formula choice, volume, free water needs, and delivery method, as well as tube site assessment and troubleshooting 1.
  • The risk of complications, including tissue damage, infection, and tube degradation, increases with prolonged placement, emphasizing the need for careful monitoring and timely removal of the NG tube 1.

From the Research

Duration of NG Tube Placement

  • The duration for which an NG tube can be in place is typically limited to a few weeks, as prolonged use can lead to complications such as lesions to the nasal wing, chronic sinusitis, gastro-oesophageal reflux, and aspiration pneumonia 2, 3.
  • According to studies, percutaneous endoscopic gastrostomy (PEG) is generally considered a more suitable option for patients who require enteral nutrition for more than 4 weeks 4, 5.
  • The use of NG tubes for more than 4 weeks is not recommended due to the increased risk of complications, and PEG is often considered a better alternative for long-term enteral nutrition 4, 5.
  • There is no specific maximum duration for NG tube placement, but it is generally recommended to limit its use to a few weeks and consider alternative options like PEG for longer-term nutrition support 2, 3.

Alternatives to NG Tubes

  • PEG is a common alternative to NG tubes for long-term enteral nutrition, as it allows for direct access to the stomach and can reduce the risk of complications associated with NG tubes 4, 5.
  • Other types of enteral access, such as nasojejunal tubes, may also be considered for patients who require long-term nutrition support 6.
  • The choice of enteral access device depends on various factors, including the patient's underlying condition, nutritional needs, and personal preferences 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Percutaneous endoscopic gastrostomy and jejunostomy: Indications and techniques.

World journal of gastrointestinal endoscopy, 2022

Research

Long-Term Nutrition: A Clinician's Guide to Successful Long-Term Enteral Access in Adults [Formula: see text].

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 2016

Related Questions

Could a patient with Herpes Simplex Virus type 1 (HSV-1) Encephalitis and underlying autoimmune diseases, who has failed swallowing tests and experienced prolonged pneumonia with a Nasogastric (NG) tube in place since diagnosis, be at increased risk of complications due to aspiration or other related factors?
What is the appropriate management and treatment plan for a patient with dysphasia?
What should be on the mayo stand during a Percutaneous Endoscopic Gastrostomy (PEG) procedure?
What is the management of dysphagia (difficulty swallowing)?
What is the management plan for an 81-year-old woman with chronic tracheal (tracheostomy) ventilator dependence, who is fed, hydrated, and medicated through a Jejunostomy (JEJ) tube that is now occluded, and can only use her Percutaneous Endoscopic Gastrostomy (PEG) tube for medications and flushing with water?
What causes Myalgic Encephalomyelitis (ME) / Chronic Fatigue Syndrome (CFS)?
What is the mechanism of action of Cap Benzpearl (Benzonatate) in reducing dry cough?
Do statins (HMG-CoA reductase inhibitors) have a role in primary prevention of cardiovascular events in individuals with Coronary Artery Disease (CAD) who have optimal Low-Density Lipoprotein (LDL) levels, specifically less than 1.5 mmol/L, without statin therapy?
What are the Centers for Disease Control and Prevention (CDC) isolation guidelines for herpes zoster (shingles)?
What is the cause of a 34-year-old female's left eye irritation, which began after rubbing her eye, with no improvement after flushing, and no associated symptoms such as visual changes, drainage, or fever, in a patient who wears contact lenses (contact lens wearer) sporadically?
What is Gleevec (Imatinib) and what are the potential side effects to watch out for?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.